Find stats on top websites
Ascendis Pharma is a global biopharmaceutical company headquartered in Denmark, focusing on applying its innovative TransCon technology to develop new therapies. The company is committed to addressing unmet medical needs in endocrinology rare diseases and oncology, aiming to improve treatment safety, efficacy, tolerability, and convenience for patients. Ascendis Pharma operates with core values of Patients, Science, and Passion and has a pipeline of product candidates in various stages of clinical development. The company collaborates with partners worldwide to develop TransCon-based products and aims to achieve blockbuster status for multiple products through global commercialization. Additionally, Ascendis Pharma is dedicated to high ethical standards and corporate responsibility, as reflected in its Code of Business Conduct & Ethics.
Major Markets
United States
Europe
ChinaKey Competitors
Select a competitor
Novo Nordisk
Pfizer
Top Marketing Channels
Novo Nordisk
- Digital Marketing
- Examples: Online Seminars, Social Media, Patient Advocacy
- Campaigns: Diabetes Awareness, Obesity Education, Insulin Innovation
- Professional Outreach
- Examples: NEJM, The Lancet, ADA Conferences
- Campaigns: Endocrinology Conferences, Medical Journals, CME Programs
- Strategic Partnerships
- Examples: Academic Institutions, Research Organizations, Patient Support Groups
- Campaigns: Partnership Programs, Collaborative Research, Educational Grants
Top Sales Channels
- Direct Sales
- Direct Sales Teams, Pharmaceutical Distributors, Hospital Networks
- Diabetes Drug Promotion, Insulin Delivery Systems, GLP-1 Receptor Agonists
- Key Account Management
- PBMs, Insurance Companies, Government Healthcare Programs
- Contract Negotiations, Formulary Placement, Volume Discounts
- Digital Channels
- Express Scripts, Teladoc, Livongo
- Online Pharmacies, Telemedicine Platforms, Digital Health Solutions
Ascendis Pharma SWOT Analysis
Strengths
Strong brand reputation
Extensive product portfolio
Global market presence
Weaknesses
Dependence on diabetes market
Limited presence in emerging markets
High R&D costs
Opportunities
Expanding into new therapeutic areas
Developing personalized medicine solutions
Leveraging digital health technologies
Threats
Increasing competition from biosimilars
Regulatory challenges
Pricing pressures
Transform Your Ideas into Action in Minutes with WaxWing
Sign up now and unleash the power of AI for your business growth
